Prevention can reduce the risk of disease, but has other consequences as well. Willingness-to-pay (WTP) is one method to analyse these multi-dimensional consequences, if the stated WTP is assumed to be a function of all the expected positive and negative effects perceived. An interview study of a community-based cardiovascular disease prevention programme in northern Sweden shows that expectations regarding reduced mortality in the community and future savings in public health care spending increase the perceived value of the programme. Among personal benefits, decreased disease risk was not positively associated with WTP, while a low level of anxiety was.
Altman D , Flora J , Fortman S , Farquhar J.The Cost-effectiveness of three Smoking Cessation Programmes . AJPH1987; 77: 162–5.
2.
Nelson D , Lasater T , Niknian M , Carleton R.Cost effectiveness of different recruitment strategies for self-help smoking cessation programs . Health Education Research1989: 4: 79–85.
3.
Nissinen A , Tuomilehto J , Kottke T , Puska P.Cost-effectiveness of the North Karelia Hypertension Program 1972–1977 . Med Care1986; 24: 767–81.
4.
Nissinen A , Tuomilehto J , Enlund H , Kottke T.Costs and benefits of community programmes for the control of hypertension . Journal of Human Hypertension1992; 6: 473–9.
5.
Kottke T , Puska P , Feldman R , Salonen J , Tuomilehto J.A decline in earning losses associated with a community-based cardiovascular disease prevention project . Med Care1982; 20: 663–75.
6.
Phillips C , Prowle M.Economics of a reduction in smoking: case study from Heartbeat Wales . J Epidemiol Community Health1993; 47: 215–23.
7.
Cohen D , Henderson J.Health, Prevention and Economics. Oxford: Oxford Medical Publications, 1988.
8.
Cohen D.Health promotion and cost-effectiveness . Health Promotion International1994; 9: 281–7.
9.
Rosén M , Lindholm L.The neglected effects of lifestyle interventions in cost-effectiveness analysis . Health Promotion International1992; 7: 163–9.
10.
Berwick D , Weinstein M.What do patients value? Willingness to pay for ultrasound in normal pregnancy . Med Care1985; 23: 881–93.
11.
Hatziandreu E , Koplan J , Weinstein M.et al. A Cost-effectiveness Analysis of Exercise as a Health Promotion Activity . AJPH1988; 78: 224–29.
12.
Gram I , Lund E , Stenker S.Quality of life following a false positive mammogram . Br J Cancer1990; 62: 1018–22.
13.
Haynes R , Sacket D , Taylor W , Gibson E , Johnson A.Increased absenteeism from work after detection and labelling of hypertensive patients . New Engl J Med1978; 299: 741–4.
14.
Cairns J , Shackley P.Sometimes sensitive, seldom specific: A review of the economics of screening . Health Economics1993; 2: 43–53.
15.
Mitchell R , Carson R.Using Surveys to Value Public Goods: The Contingent Valuation Method. Washington D.C.: Resources for the Future, 1990.
16.
Hausman J. (eds) Contingent Valuation- A Critical Assessment. Amsterdam: North-Holland, 1993.
17.
Brännström I , Rosén M , Wall S , Weinehall L.Local health planning and intervention–The case of a Swedish municipality . Scand J Prim Health Care1988; suppll: 57–64.
18.
Johannesson M , Jönsson B.Economic evaluation in health care: Is there a role for cost-benefit analysis?Health Policy1991; 17: 1–23.
19.
Acton P.Evaluating Public Programmes to Save Lives: The Case of Heart Attacks. Santa Monica: Rand, 1973.
20.
Appel L , Steinberg E , Powe N , Anderson G , Dwyer S , Faden R.Risk Reduction From Low Osmolality Contrast Media. What Do Patients Think It Is Worth? . Med Care1990; 28: 324–37.
21.
Donaldson C.Willingness to pay for public-provided goods: A possible measure of benefit?J Health Econ1990; 9: 103–18.
22.
Gafni A.Willingness-to-Pay as a Measure of Benefits. Relevant Questions in the Context of Public Decision making About Health Care Programmes . Med Care1991; 29: 1246–52.
23.
Johannesson M , Jönsson B , Borgquist L.Willingness to pay for antihypertensive therapy–results of a Swedish pilot study . J Health Econ1991; 10: 461–74.
24.
Johannesson M , Åberg H , Agréus L , Borgquist L , Jönsson B.Cost-benefit analysis of non-pharmacological treatment of hypertension . J Internal Med1991; 230: 307–12.
25.
Johannesson M , et al.Willingness to pay for antihypertensive therapy–further aspects . J Health Econ1993; 12: 95–108.
26.
Rice D , et al.Cost of Injury in the United States: A Report to Congress. Institute for Health and Ageing, University of California, San Francisco and Injury Prevention Centre, The John Hopkins University, 1989.
27.
Thompson M.Willingness to Pay and Accept Risks to Cure Chronic Disease . AJPH1986; 76: 392–6.
28.
Brännström I , Lindblad I.Mass Communication and Health Promotion; The Power of the Media and Public Opinion . Health Communication1994; 6: 21–36.
29.
Lindholm L , Rosén M , Weinehall L , Asplund K.Cost-effectiveness and equity of a community based cardiovascular disease prevention programme in Norsjö, Sweden . J Epidemiol Community Health1996; 50: 190–5.
30.
Lindholm L.Rosén M, Hellsten G. Are people willing to pay for a community-based preventive programme?-A case study from Norsjö, Sweden . Int J of Technol Assess Health Care1994; 10: 317–24.
31.
Bollen K , Jackman R.Regression Diagnostics: An Expository Treatment of Outliers and Influential Cases. Newbury Park CA: Sage, 1990.
32.
Pindyck R , Rubinfeld D.Econometric models and economic forecasts. Singapore; McGraw-Hill, 1991.
33.
Cody R , Smith J.Applied Statistics and the SAS Programming Language. New York: North-Holland, 1991.
34.
Freund R , Litell R.SAS System for Regression. Cary NC; SAS Institute Inc., 1991.
35.
Law MR , Wald NJ , Thompson SG.By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease . BMJ1994; 308: 362–72.
36.
McFadden D , Leonard G.Issues in the Contingent Valuation of Environmental Goods: Methodologies for Data Collection and Analysis. In: Hausman J , ed. Contingent Valuation- A Critical Assessment. Amsterdam: North-Holland, 1993.
37.
NOAA, Report of the NOAA (National Oceanic and Atmospheric Administration) Panel on Contingent Valuation, Department of Commerce, US, 1993.
38.
Kemp M , Maxwell C.Exploring a Budget Context for Contingent Valuation Estimates. In: Hausman J , ed. Contingent Valuation-A Critical Assessment. Amsterdam: North-Holland, 1993.
39.
Torrance G.Measurement of Health State Utilities for Economic Appraisal . J Health Econ1986; 5: 1–30.
40.
Arrow K.Uncertainty and the Welfare Economics of medical care . The American Economic Review1963; LIII: 943–73.
